New vaccines and screening can reduce cervical cancer incidence in poor countriesBMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a1545 (Published 03 September 2008) Cite this as: BMJ 2008;337:a1545
- Rory Watson
New vaccines and screening tests can help to achieve a major reduction in the incidence of cervical cancer in developing countries, concludes research presented last week at the world cancer congress of the International Union Against Cancer.
Francesc Xavier Bosch of the Catalan Institute of Oncology in Barcelona, Spain, coordinated a monograph that brings together research analysing the cost effectiveness of introducing human papillomavirus (HPV) vaccination and new screening methods into poorer countries in the world (www.kaizo.net/releases/cervicalmonograph/).
“The discovery of HPV as the cause of cervical cancer has shaken a field that was stagnating,” he said, “and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial